Company intelligence / Profile preview

Prodigy Silk

Lam Dong Province, Vietnam

Ownership: Private
Development stage: Other

Overview

Prodigy Silk, a wholly owned subsidiary of Kraig Biocraft Laboratories, operates as the company's primary commercial production arm for recombinant spider silk, with two modern rearing centers in a premier Southeast Asian silk-producing region. Since early 2024, production has exceeded all previous cumulative output, signaling a transition from R&D to commercial scale. Kraig Labs is in discussions with global luxury, sportswear, and athletic equipment brands for initial deliveries.

Therapeutic areas: OtherImmunology
Modalities: Recombinant protein
Industry: Non-Drug Biotech

Partnerships

Lam Dong Agro-Forestry Research and Experiment Center (LAREC)Vietnam Sericulture Association (VSA)

Beyond the preview

Go deeper on Prodigy Silk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prodigy Silk.

Explore the full profile